HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,117-1,128 of 1,979
Drug study icon
WithdrawnNCT01543139

Cytidine- and Creatine-Containing Drug in Treating Depression in bipolarity

Official study title

A Double-Blind, Placebo-Controlled Trial of Combined Cytidine- and Creatine-Containing Drug and Dietary Supplement in the Treatment of the Bipolar Depression

This study was withdrawn before enrollment.

In Seoul
Bipolarity, DepressionMedication studyAges 19–65
Countries
South Korea
Sponsor
Ewha Womans University
Drug study icon
CompletedNCT00186186

Depakote ER in Depression in bipolarity

What is this study about?

Researchers studied Depakote ER to find out how it affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

In Stanford
Bipolarity, DepressionMedication studyAges 18–99
Countries
United States
Sponsor
Stanford University
Drug study icon
CompletedNCT00226343

Depakote-ER for Depressive and Depression in bipolarity

Official study title

Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression

This study has finished and is no longer accepting participants.

Location not clearly listed
Bipolarity, DepressionMedication studyAges 18–65
Countries
Sponsor
Cambridge Health Alliance
Drug study icon
CompletedNCT00274677

Depression And Bipolarity

Official study title

A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-Week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Depression in Patients With Type II Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Burbank
Bipolarity, DepressionPlacebo comparisonAges 18+
Countries
United States
Sponsor
GlaxoSmithKline
Drug study icon
CompletedNCT00203528

Divalproex ER vs. Risperidone for Bipolarity With Comorbid Addiction

Official study title

Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder

This study has finished and is no longer accepting participants.

In Tuscaloosa
Bipolarity, Addiction, ...Medication studyAges 19–65
Countries
United States
Sponsor
Tuscaloosa Research & Education Advancement Corporation
Drug study icon
WithdrawnNCT05060549

Dopamine D3 Receptor Occupancy in Depression in bipolarity

What is this study about?

Researchers are studying Cariprazine to find out how it affects depression symptoms in people with bipolarity during a depressive episode.

This study was withdrawn before enrollment.

In New York
Bipolarity, DepressionMedication studyAges 18–60
Countries
United States
Sponsor
New York State Psychiatric Institute
Behavioral study icon
CompletedNCT01483391

Early Intervention for Youth at Risk for Bipolarity

Official study title

Early Intervention for Youth at Risk for Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
Bipolarity, DepressionBehavioural studyAges 9–17
Countries
United States
Sponsor
University of California, Los Angeles

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.